What Capital Management Steps Did Bravura Solutions Ltd (ASX:BVS) Announce With Its FY26 Results?

Sonal Goyal

19 October 2026 05:00 PM AEDT

What Capital Management Steps Did Bravura Solutions Ltd (ASX:BVS) Announce With Its FY26 Results?

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

Bravura reported FY26 underlying revenue from customers of $282.6 million, up 9.6%, and underlying NPAT of $63.1 million.
The company declared a final dividend of 8.31 cents and a special dividend of 6.69 cents per share, both unfranked.
FY27 guidance is revenue of $280 million to $300 million and cash EBITDA of $84 million to $94 million.

Bravura Solutions Ltd (ASX:BVS) shares were priced at $3.21 during the trading session on 19 October 2026, up 0.31%. Bravura provides software solutions for the wealth management and life insurance sectors. On 12 August 2026, the company released its FY26 results and dividend announcement for the year ended 30 June 2026, which also covers a new debt facility, an on-market share repurchase and FY27 guidance. The price data relates only to the 19 October 2026 session and is separate from the release date.

FY26 financial results

Underlying revenue from customers was $282.6 million, up 9.6% despite foreign exchange headwinds in the second half. Recurring revenue was $165.0 million, up 6.9% from $154.3 million. Underlying cash EBITDA was $77.1 million, a 27.3% margin, up $33.3 million on FY25, and underlying NPAT was $63.1 million, up $38.7 million.

The company said all underlying figures exclude the impact of a perpetual licence agreement with Fidelity International in FY25 and the impact of deferred tax asset recognition in FY26. Bravura ended the year with $50.3 million of cash and no debt.

Dividends and capital management

Bravura declared a final ordinary dividend of $37.3 million (8.31 cents per share) and a special dividend of $30.0 million (6.69 cents per share), a combined 15.0 cents per share. Total dividends declared for FY26 were $113.2 million (25.23 cents per share). The dividends are unfranked, the dividend reinvestment plan remains suspended, the record date was 25 August 2026 and the payment date was 3 September 2026.

The company also announced an on-market share repurchase of up to $50 million over a period of up to 12 months from 31 August 2026, funded from existing cash and, if required, its debt facilities. The release states that the number of shares purchased, the price and the timing depend on the share price, market conditions and forecast capital needs, and that the company may vary, suspend or terminate the program.

New debt facilities and other updates

On 12 August 2026, Bravura entered into facilities with HSBC providing up to $100 million of committed funding for working capital. The agreement has two $50 million secured facilities: an amortising term loan and a revolving credit facility, each with a three-year maturity and an interest rate based on BBSY plus a margin.

Other updates include admission to trading on AIM, a market operated by the London Stock Exchange, on 28 July 2026. The company also reported that its Midwinter digital solutions are available to more than 6 million members, that its Sonata Alta platform processed tens of millions of transactions with more than 99% straight-through processing, and that it has a team of about 950.

Sector backdrop

Wealth management and life insurance software is typically sold under multi-year licence, support and hosting arrangements, so companies in this area report recurring revenue and cash-based earnings measures. Customers are financial institutions with regulatory obligations, which affects implementation timelines and contract structures. Bravura earns a large share of its revenue in British pounds, and the release notes foreign exchange headwinds in the second half and bases FY27 guidance on an exchange rate of 1.90 Australian dollars to the pound.

Risks shareholders should weigh

The press release and the wider operating environment point to several considerations that shareholders may wish to weigh:

Revenue is exposed to currency movements: FY27 guidance assumes 1.90 AUD to 1.00 GBP, compared with 1.98 in FY26.
The dividends are unfranked and the combined distribution and repurchase program will draw on cash and potentially the new debt facilities, which are senior secured over all assets.
The on-market repurchase does not guarantee that any shares will be bought and may be varied, suspended or terminated.
FY27 revenue guidance of $280 million to $300 million compares with FY26 underlying revenue from customers of $282.6 million.
Underlying figures exclude the FY25 Fidelity International licence agreement and a FY26 deferred tax asset recognition, so they differ from statutory results.

What's next

The company guides for FY27 revenue of $280 million to $300 million and cash EBITDA of $84 million to $94 million, assuming 1.90 AUD to 1.00 GBP. The repurchase program runs for up to 12 months from 31 August 2026, and full details are in an Appendix 3C. The release adds that the Board will continue to assess its capital management strategy, and that the company continues to develop workplace pensions, employer engagement and annuity functionality in the UK.

FAQs

Q: What dividends did Bravura declare with its FY26 results?

A:A final ordinary dividend of 8.31 cents and a special dividend of 6.69 cents per share, both unfranked, totalling 15.0 cents.

Q: What is the size of the on-market share repurchase?

A:Up to $50 million over a period of up to 12 months from 31 August 2026.

Q: What is Bravura's FY27 guidance?

A:Revenue of $280 million to $300 million and cash EBITDA of $84 million to $94 million, assuming 1.90 AUD to 1.00 GBP.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.